Company Profiles

driven by the PitchBook Platform

Atanse

Description

Developer of stereotactic instruments for neurological diseases. The company specializes in developing stereotactic instruments that enables the treatment of neurological diseases through intracerebral therapeutic delivery technology.

2010

Founded

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

$50k

Latest Deal Amount

$50k

Total Amount Raised

Description

Developer of stereotactic instruments for neurological diseases. The company specializes in developing stereotactic instruments that enables the treatment of neurological diseases through intracerebral therapeutic delivery technology.

Website:

www.atanse.com

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Surgical Devices

Other Industries

Other Devices and Supplies

Primary Office

68 Leonard Street Belmont, MA 02478United States +1 (339) 225-9639
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Atanse's full profile, request a free trial.

Atanse Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Atanse Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
NeuroLaunchAccelerator/IncubatorMinority000 0000000 0000
NeuroLaunch Accelerator/Incubator

Atanse Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Mike KellyChief Executive Officer
Miles Cunningham Ph.DFounder & Chief Scientific Officer
Mike Kelly Chief Executive Officer
Miles Cunningham Ph.D Founder & Chief Scientific Officer

Atanse Board Members (1)

NameRepresentingRoleSinceContact
Info
Edward Berger Ph.DAtanseAdvisor & Board Member000 0000
Edward Berger Ph.D Advisor & Board Member Atanse
Request full access to PitchBook